Immune Control of HIV

Area of Science:

• Immunology and Virology
• Infectious Diseases
• Genetics and Molecular Biology

Background:

• Human immunodeficiency virus (HIV) infects CD4+ T cells, causing immune decline and Acquired Immunodeficiency Syndrome (AIDS).
• Despite combination antiretroviral therapy (cART), a latent HIV reservoir persists, necessitating lifelong treatment.
• HIV-specific CD8+ cytotoxic T lymphocytes (CTLs) control viral replication but fail to durably suppress HIV without cART.

Purpose of the Study:

• To investigate the characteristics of HIV-1 controllers (HCs) who achieve durable viral suppression without cART.
• To explore the role of CTL responses and human leukocyte antigen (HLA) alleles in the HC phenotype.
• To identify mechanisms for advancing HIV cure and vaccine development.

Main Methods:

• Analysis of HIV-1-specific CTL responses in elite controllers.
• Association studies of protective HLA alleles with enduring HIV-1 control.
• Investigation of molecular mechanisms underlying CTL-mediated viral suppression.

Main Results:

• Elite controllers (<1% of cART-naive individuals) exhibit durable viral suppression, non-progression to AIDS, and no transmission.
• Robust HIV-1-specific CTL responses and protective HLA alleles are linked to the HC phenotype.
• Understanding these mechanisms offers insights into HIV-1 control.

Conclusions:

• HIV-1 controllers represent a model for functional cure, demonstrating the potential for immune-mediated viral suppression.
• Further research into CTLs and HLA associations in HCs is crucial for developing effective HIV cures and vaccines.
• Identifying protective immune mechanisms could guide therapeutic strategies to achieve durable HIV remission.